Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S-16257-2 and S-16260-2

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1293-1301

  Delpón, Eva ^a   Valenzuela, Carmen ^a   Pérez, Onésima ^a   Franqueza, Laura ^a   Gay, Pilar ^a   Snyders, Dirk J ^b   Tamargo, Juan ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bradycardic agents; hKv1.5 channels; S 16257 2; S 16260 2; Stereoselectivity

Indexed keywords

IVABRADINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DISSOCIATION CONSTANT; DRUG BINDING; DRUG POTENCY; L CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPOLARIZATION;

EID: 0029928144     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16728.x     Document Type: Article

References (39)

1. ARIËNS, E.J. (1993). Nonchiral, homochiral and composite chiral drugs. Trends Pharmacol. Sci., 14, 68-5.
2. + channels: II. The components of gating currents and a model of channel activation. Biophys. J., 66, 1011-1021.
3. + current in isolated adult rat atrial myocytes. Am. J. Physiol., 260, H1236-1247.
4. CAMPBELL T.J. (1983). Importance of physico-chemical properties in determining the kinetics of the effects of class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle. Br. J. Pharmacol., 80, 33-40.
5. + current by almokalant in rabbit ventricular myocytes. Circ. Res., 73, 857-868.
6. CHOI, K.L., MOSSMAN, C., AUBE, J. & YELLEN, G. (1993). The internal quaternary ammonium receptor site of Shaker potassium channels. Neuron, 10, 533-541.
7. COLATSKY, T.J., FOLLMER, C.H. & STARMER, C.F. (1990). Channel specificity in antiarrhythmic action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation, 82, 2235-2242.
8. COURTNEY, K.R. (1987). Quantitative structure/activity relation based on use-dependent block and repriming kintics in myocardium. J. Mol. Cell. Cardiol., 19, 319-330.
9. + current in guinea-pig ventricular myocytes. Voltage-independent and time-dependent block of the slowly activating component. Circ. Res., 76, 223-235.
10. DELPON, E., VALENZUELA, C., PEREZ, O., SNYDERS, D. & TAMARGO, J. (1994). Effects of the enantiomers of a new bradycardic agent on hKv1.5 channels. Biophys. J., 66, A206.
11. FEDIDA, D., WIBLE, B., WANG, Z., FERMINI, B., FAUST, F., NATTEL, S. & BROWN, A.M. (1993). Identity of a novel delayed rectifier current from human heart with a cloned K channel currrent. Circ. Res., 73, 210-216.
12. FOLLMER, C., CULLINAN, C. & COLATSKY, T. (1992). Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: evidence for open channel block and unblock. Cardiovasc. Res., 26, 1121-1130.
13. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, M.B. & SIGWORTH, F.J. (1991). Improved patch clamp tecnique for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
14. HJALMARSON, Å. (1991). Reduction of heart rate-Really a new concept in treating angina pectoris? In Sinus Node Inhibitors, ed. Hjalmarson, Å. & Remme, W.J. pp. 1-8. Darmstadt: Steipkopff Verlag.
15. HOSOI, S. & SLAYMAN, C. (1985). Membrane voltage, resistance, and channels switching in isolated mouse fibroblastic (L cells): a patch-electrode analysis. J. Physiol., 367, 267-290.
16. JECK, C.D. & BOYDEN, P.A. (1992). Age-related appearance of outward current may contribute to developmental differences in ventricular repolarization. Circ. Res., 71, 1390-1403.
17. KOBINGER, W. & LILLE, C. (1984). Cardiovascular characterization of UL-FS 49, 1, 3, 4, 5-tetrahydro-7, 8-dimethoxy-3-[3-[[2-(3, 4-dimethoxyphenyl)ethyl]methylamino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new 'specific bradycardic agent'. Eur. J. Pharmacol., 104, 9-18.
18. KOBINGER, W. & LILLE, C. (1987). Specific bradycardic agents, a novel pharmacologic class. Eur. Heart J., 8 (suppl. L), 7-15.
19. KOREN, G., LIMAN, E.R., LOGOTHETIS, D.E., NADAL-GUINARD, B. & HESS, P. (1990). Gating mechanisms of a cloned potassium channel expressed in frog oocytes and mammalian cells. Neuron, 2, 39-51.
20. + channel protein in explanted cardiac tissue. J. Clin. Invest., 96, 282-292.
21. PEREZ, O., GAY, P., FRANQUEZA, L., CARRON, R., VALENZUELA, C., DELPON, E. & TAMARGO, J. (1995). Comparative effects of two enantiomers, S 16257 and S 16260, two new bradycardic agents, on isolated guinea pig cardiac preparations. Br. J. Pharmacol., 115, 787-794.
22. + channel cloned from human heart. Mol. Pharmacol., 44, 1240-1245.
23. + channel cloned from human heart. Mol. Pharmacol., 44, 642-648.
24. REIFFEN, MM., EBERLEIN, W., MULLER, P., PSIORZ, M., NOLL, K., HEIDER, J., LILLIE, C., KOBINGER, W. & LUGER, P. (1990). Specific bradycardic agents. I. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a new class of compounds exerting anti-ischemic properties. J. Med. Chem., 33, 1496-1504.
25. SCOTT, A.K. (1991). Stereoisomers in clinical pharmacology. Drug News Prospects, 4, 476-482.
26. SNYDERS, D., KNOTH, K., ROBERDS, S. & TAMKUN, M. (1992). Time-, state- and voltage-dependent block by quinidine of a cloned human cardiac channel. Mol. Pharmacol., 41, 332-339.
27. SNYDERS, D., TAMKUN, M. & BENNETT, P. (1993). A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J. Gen. Physiol., 101, 513-543.
28. SNYDERS, D. & YEOLA, S. (1995). Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ. Res., 77, 575-583.
29. + channels. In Cardiac Electrophysiology. From Cell to Bed Side. ed. Zipes. D & Jalife. J. pp 21-31. Philadelphia: W.B. Saunders Co.
30. + channel cDNAs from human ventricle. FASEB J., 5, 331-337.
31. THOLLON, C., CAMBARRAT, C., VIAN, J., PROT, J-F., PEGLION, J.L. & VILAINE, J.P. (1994). Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig preparations: comparisons with UL-FS 49. Br. J. Pharmacol., 112, 37-42.
32. VALENZUELA, C., DELPON, E., FRANQUEZA, L., GAY, P., PEREZ, O., TAMARGO, J. & SNYDERS, D.J. (1995a). Class III antiarrhythmic effects of zatebradine: time-, state-, use- and voltage-dependent block of hKv1.5 channels. Circulation, (in press).
33. VALENZUELA, C., DELPON, E., PEREZ, O., TAMKUN, M., TAMARGO, J. & SNYDERS, D. (1995b). Stereoselective bupivacaine block of the human cardiac delayed rectifier Kv1.5 channel. Biophys. J., 69, 418-427.
34. WALLENSTEIN, S., ZUCKER, C. & FLEISS, J. (1980). Some statistical methods useful in circulation research. Circ. Res., 47, 1-9.
35. + current similar to Kv1.5 cloned channel currents. Circ. Res., 73, 1061-1076.
36. WOODHULL, A.M. (1973). Ion blockade of sodium channels in nerve. J. Gen. Physiol., 61, 687-708.
37. YANG, T., PRAKASH, C., RODEN, D. & SNYDERS, D. (1995). Block of a human cardiac potassium channel by the antihistamine terfenadine: mechanisms and stereoselectivity. Br. J. Pharmacol., 115, 267-274.
38. + channel. Science, 251, 939-942.
39. ZAGOTTA, W.N. & ALDRICH, R.W. (1990). Voltage-dependent gating of Shaker A-type potassium channels in Drosophila muscle. J. Gen. Physiol., 95, 29-60.